# Islet Cell Transplant for Type 1 Diabetes

> **NCT01909245** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Allogenic Human Islet Cells
- **DRUG:** Immunosuppressive Agents
- **DRUG:** Gastrin 17

## Key facts

- **NCT ID:** NCT01909245
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-10-16
- **Primary completion:** 2026-09-22
- **Final completion:** 2026-09-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01909245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01909245, "Islet Cell Transplant for Type 1 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01909245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*